vimarsana.com

Latest Breaking News On - Nyse cck - Page 9 : vimarsana.com

Crown (NYSE:CCK) Issues FY 2023 Earnings Guidance

Crown (NYSE:CCK – Get Free Report) updated its FY 2023 earnings guidance on Monday. The company provided earnings per share guidance of $6.00-$6.10 for the period, compared to the consensus earnings per share estimate of $6.20. The company issued revenue guidance of -. Crown also updated its Q4 guidance to $1.40-1.50 EPS. Crown Trading Down […]

KBC Group NV Sells 18,674 Shares of Crown Holdings, Inc (NYSE:CCK)

KBC Group NV lessened its holdings in Crown Holdings, Inc. (NYSE:CCK – Free Report) by 17.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 90,179 shares of the industrial products company’s stock after selling 18,674 shares during the quarter. KBC Group NV owned approximately […]

Crown Holdings, Inc (NYSE:CCK) Given Average Rating of Moderate Buy by Analysts

Shares of Crown Holdings, Inc. (NYSE:CCK – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are covering the company, Marketbeat.com reports. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price objective among […]

Citigroup Cuts Crown (NYSE:CCK) Price Target to $106 00

Crown (NYSE:CCK – Get Free Report) had its target price decreased by research analysts at Citigroup from $114.00 to $106.00 in a research note issued on Tuesday, FlyOnTheWall reports. Citigroup’s price target points to a potential upside of 26.64% from the company’s previous close. A number of other brokerages have also recently issued reports on […]

Crown (NYSE:CCK) Upgraded at StockNews com

StockNews.com upgraded shares of Crown (NYSE:CCK – Free Report) from a sell rating to a hold rating in a research note released on Thursday morning. Several other research analysts also recently commented on CCK. Barclays lifted their price target on Crown from $95.00 to $110.00 and gave the stock an overweight rating in a research […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.